These adverse effects have led to numerous lawsuits against Novo Nordisk, alleging that the company failed to adequately warn users about the potential risks associated with Semaglutide
When to Speak to Your Healthcare Provider Whilst some degree of continued hunger on Ozempic may be normal, particularly during dose titration, certain situations warrant discussion with your GP, practice nurse, or diabetes specialist nurse (DSN)
MASLD is the most common form of liver diseaseaffecting a quarter of adults in the U.S.though it often doesnt cause visible symptoms
Dit kan zorgverleners en patinten in de toekomst helpen om bijwerkingen te voorkomen, te herkennen en behandelen
Semaglutide is administered via a once-weekly subcutaneous injection
Receive ongoing support Enjoy unlimited provider messaging, follow-up visits, and app features that make it easy to track weight loss, lifestyle goals & side effects